Tag: drug injury
-
Factors In Assessing Association Between Valvular Heart Disease And Use Of Dostinex Or Permax
Two Medical Journal Articles Review The Published Research And Suggest Ways To Avoid Cardiac Valve Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) In March 2007 the FDA announced that Permax (pergolide) would be voluntarily…
-
Case Report: Man Using Diabetes Medication Januvia Develops Elevated Hepatic Enzymes
Authors Suggest That Certain Patients Starting Januvia Should Have Their Liver Function Monitored (Posted by Tom Lamb at DrugInjuryWatch.com) In the recent past we considered whether Januvia (sitagliptin) can cause pancreatitis in patients using…
-
Fibromyalgia Drug Savella Should Be Pulled From Market, Says Public Citizen Group
January 2010 Petition Letter To FDA Is Sent One Year After The Medication Was Approved For Sale In U.S. (Posted by Tom Lamb at DrugInjuryWatch.com) On January 21, 2010 the Health Research Group arm…
-
Should Meridia Remain On Market? FDA Says “Yes” (For Now At Least), European Drug Regulators Say “No”
Difference Of Opinion Suggests There Could Be A Possible Meridia Recall In U.S. Before The FDA Holds Its Public Advisory Meeting In September 2010(Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Abbott Pulls Meridia in U.S. Amid…
-
When Will Michigan State Senate Vote Whether To Repeal Statute Prohibiting Drug Injury Lawsuits
State Senate Republicans Move In January 2010 To Delay, Again, Any Action Regarding This "FDA Defense" Law (Posted by Tom Lamb at DrugInjuryWatch.com) As you may be aware, Michigan is the only state in the…
-
FDA Introduces A New Web Site Intended To Give The Public More Insight About Agency’s Work
FDA Basics: Site Seeks To Present Information To Consumers And Patients In Useful And User-Friendly Format (Posted by Tom Lamb at DrugInjuryWatch.com) On January 12, 2009 Dr. Joshua Sharfstein, Principal Deputy Commissioner of the…
-
FDA Wants Studies Done On Byetta Safety, With Focus On Pancreatitis, Pancreatic Cancer, Thyroid Neoplasm, And Acute Renal Failure
FDA Letter About Byetta Sent To Amilyn In October 2009; Drug Company Tries To Downplay, But Investors React When They Learn About It In December 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) On October…
-
Anemia Drugs Procrit And Aranesp May Increase Twofold The Risk Of Potentially Fatal Blood Clots
Results From Large Long-Term Study Show Association Between These Erythropoiesis-Stimulating Agents And Venous Thromboembolism (Posted by Tom Lamb at DrugInjuryWatch.com) In late October 2009 we learned that the results from the Trial to Reduce Cardiovascular…